Business Wire

NY-IMPACTWAYV

9.3.2021 15:02:11 CET | Business Wire | Press release

Share
ImpactWayv™ Completes Beta Test of Its Social Impact Media and Technology Platform and Announces Upcoming Public Launch

ImpactWayv, Inc. is pleased to announce it has recently concluded the private beta test of ImpactWayv ™, the company’s pioneering social impact media and technology networking platform that will launch publicly this spring. ImpactWayv connects people, businesses and philanthropy – for good.

Designed to be a healthier and more meaningful alternative to major social networking platforms, ImpactWayv is the next generation digital ecosystem where people, businesses and nonprofits engage to effect positive change and maximize social impact. ImpactWayv unites disparate sources of information, initiatives and innovations from across the global social good sector under one digital roof to generate greater and more efficient collective impact.

Reception to ImpactWayv’s invitation-only private beta test was overwhelmingly positive, with individual, business and nonprofit users confirming the strong need for this type of holistic social impact-focused platform within today’s social media landscape. Users were guided through ImpactWayv’s core user flow to validate design, functionality and usability. The results reinforced the platform’s underlying social impact thesis, focused on fostering universal social good through a continuous cycle of engagement, interaction and empowerment.

At a time of unprecedented interest in social action globally, ImpactWayv provides the social media network solution that addresses the convergence of three major trends in society:

  • People’s hunger for greater purpose and meaning in all aspects of life – family, friends, social interaction, employment, consumer relationships, investing, donating and volunteering.
  • Businesses’ imperative to demonstrate to all stakeholders and the world their social good efforts.
  • Nonprofits’ pressing need for global connectivity and adoption of private sector business and marketing principles, supporting sustainability and mission achievement.

“ImpactWayv is uniquely positioned for this moment in time,” said George Dolatly, Co-Founder and President of ImpactWayv, Inc. “Our groundbreaking platform creates the opportunity for people, businesses and nonprofits to work together efficiently and effectively on all fronts to maximize social good and positive change.”

ImpactWayv will also feature a digital “Social Impact as a Service” (SIaaS) offering to both businesses and nonprofits to best address emerging social impact trends such as business models that integrate the values and metrics of Environmental, Social & Governance (ESG) criteria, Corporate Social Responsibility (CSR) and the United Nations Sustainable Development Goals (SDGs). This will allow ImpactWayv to provide advisory and support services through a global team of social impact sector leaders, experts and experienced professionals.

“Our current climate has demonstrated just how motivated people are to come together to foster positive social change,” said Benji Bernstein, Co-Founder and Chief Technology Officer of ImpactWayv, Inc. “The time is now for a new digital ecosystem that meets this critical moment – a social media network created to unite and empower people, businesses and nonprofits for greater collective impact, via a continuous cycle of social good. ImpactWayv is that platform, a breakthrough force for good.”

About ImpactWayv, Inc.

ImpactWayv, Inc. is a social impact media and technology company, consisting of thought leaders and doers from across the business, nonprofit and technology sectors. ImpactWayv was created to disrupt and transform the worlds of business and philanthropy through technology – to advance universal social good. For more information or to be added to the ImpactWayv user list, please visit: www.ImpactWayv.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release

The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e

Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release

Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye